Silver nanoparticles synthesized from Pseudomonas aeruginosa pyoverdine: Antibiofilm and antivirulence agents
The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative...
Saved in:
Published in | Biofilm Vol. 7; p. 100192 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.06.2024
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects.
•Pyoverdine from Pseudomonas aeruginosa was used as a biological corona to synthesize AgNPs.•PVD-AgNPs effectively inhibited and eradicated initial stage and mature biofilms.•PVD-AgNPs increased the susceptibility of tetracycline and amphotericin B towards mature biofilm.•PVD-AgNPs attenuated several virulence properties in P. aeruginosa.•The suppression of genes associated with biofilm and virulence validates its phenotypic effects. |
---|---|
AbstractList | The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of -36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards , , , , , and in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of and . Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in . The inhibition of gene expression of biofilm and virulence-associated genes in validates its phenotypic effects. The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of -36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa , Listeria monocytogenes , Staphylococcus aureus , Streptococcus mutans , Escherichia coli , and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans . Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa . The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. • Pyoverdine from Pseudomonas aeruginosa was used as a biological corona to synthesize AgNPs. • PVD-AgNPs effectively inhibited and eradicated initial stage and mature biofilms. • PVD-AgNPs increased the susceptibility of tetracycline and amphotericin B towards mature biofilm. • PVD-AgNPs attenuated several virulence properties in P. aeruginosa. • The suppression of genes associated with biofilm and virulence validates its phenotypic effects. The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. •Pyoverdine from Pseudomonas aeruginosa was used as a biological corona to synthesize AgNPs.•PVD-AgNPs effectively inhibited and eradicated initial stage and mature biofilms.•PVD-AgNPs increased the susceptibility of tetracycline and amphotericin B towards mature biofilm.•PVD-AgNPs attenuated several virulence properties in P. aeruginosa.•The suppression of genes associated with biofilm and virulence validates its phenotypic effects. |
ArticleNumber | 100192 |
Author | Tabassum, Nazia Jeong, Geum-Jae Kim, Young-Mog Khan, Fazlurrahman Jo, Du-Min |
Author_xml | – sequence: 1 givenname: Nazia surname: Tabassum fullname: Tabassum, Nazia organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea – sequence: 2 givenname: Fazlurrahman orcidid: 0000-0002-4902-3188 surname: Khan fullname: Khan, Fazlurrahman email: fkhan055@pknu.ac.kr organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea – sequence: 3 givenname: Geum-Jae surname: Jeong fullname: Jeong, Geum-Jae organization: Department of Food Science and Technology, Pukyong National University, Busan, 48513, Republic of Korea – sequence: 4 givenname: Du-Min surname: Jo fullname: Jo, Du-Min organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea – sequence: 5 givenname: Young-Mog surname: Kim fullname: Kim, Young-Mog organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38544742$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kclqHDEQhoVxiNc3MKGPucyktPSWQ4IxcWIwJJD4LNRSaayhW5pI3QPjp48mPTH2JQchUfrrq-U_I8c-eCTkisKSAq0-rJedC7YflgyYyCGgLTsip6xsYcGgLo9fvE_IZUprAGCc8prBW3LCm1KIWrBTMvx0_RZj4ZUPGxVHp3tMRdr58RGTe0JT2BiG4kfCyYQheJUKhXFaOR-SKja7kJON8_ixuPaj2zfl-qFQ3uQzuq2LU49eY6FW6Md0Qd5Y1Se8PNzn5OH2y6-bb4v771_vbq7vF7rkMC4M70C1TccrVrMONSpbMU21ooxpYYXVVVcDaEprLQRvTFNX2lQlFXXXtFXFz8ndzDVBreUmukHFnQzKyb-BEFfyMKuktm5LC8h10wkNttMGMgpoLm5ag5n1eWZtpm5Ao_McUfWvoK9_vHuUq7CVFHIrtOWZ8P5AiOH3hGmUg0sa-155DFOSHKgAKKFlWSpmqY4hpYj2uQ4FuXderuXsvNw7L2fnc9q7lz0-J_3zOQs-zQLMW986jDJptzfGuIh6zGtx_6_wBxOixi4 |
CitedBy_id | crossref_primary_10_1016_j_resmic_2024_104211 crossref_primary_10_3390_antibiotics13040347 |
Cites_doi | 10.3390/antibiotics11111524 10.1093/cid/ciac489 10.1002/jobm.202000678 10.1371/journal.pone.0089614 10.1128/JCM.01934-17 10.1007/s00203-021-02505-1 10.1007/s42770-021-00624-x 10.1371/journal.pone.0176883 10.1016/j.matchemphys.2020.122898 10.1080/21691401.2018.1518909 10.1016/j.ebiom.2017.05.026 10.3390/md20080527 10.1038/nrmicro2415 10.1080/14787210.2021.1908125 10.1097/CCM.0b013e3181e96b91 10.1080/1040841X.2023.2282459 10.1016/j.mimet.2019.02.010 10.1007/s11356-016-8170-3 10.1016/S0140-6736(21)02724-0 10.1186/s13756-019-0533-3 10.1016/j.febslet.2011.12.004 10.1016/j.cplett.2016.11.037 10.3390/jof7121070 10.1016/j.jep.2020.113699 10.1186/s12951-023-01909-z 10.1128/AEM.04220-14 10.3390/biomedicines10030628 10.1038/nprot.2008.73 10.1016/j.jare.2022.12.013 10.1080/1040841X.2020.1822278 10.3390/pathogens11030300 10.1093/cid/ciy776 10.1128/CMR.05041-11 10.1038/s41598-019-52975-z 10.1007/s00284-010-9722-2 10.1089/mdr.2020.0089 10.1016/j.chemosphere.2022.134497 10.1038/s41392-022-01056-1 10.1016/j.ijmm.2017.09.016 10.1021/acsomega.2c06789 10.1007/s13205-019-1841-2 10.1038/s41579-022-00682-4 10.3390/antibiotics12040726 10.3389/fcimb.2017.00041 10.1038/s41467-022-32249-5 10.1016/j.tim.2016.12.010 10.1078/1438-4221-00196 10.3390/molecules26041142 10.1038/s41579-022-00720-1 10.5001/omj.2019.37 10.1016/j.chemosphere.2020.128580 10.1038/s41579-021-00649-x 10.1155/2017/9584703 10.3934/microbiol.2018.2.274 10.1016/j.micres.2014.05.005 10.1007/s00253-019-10190-w 10.1039/D2NR03632K 10.3390/md21020123 10.1128/AAC.02533-15 10.1016/j.ijantimicag.2023.106941 10.3390/md17040208 10.3390/md19110601 10.3390/nano12010130 10.3389/fmicb.2021.741493 10.1038/s41396-022-01218-7 10.1016/j.micpath.2023.106416 10.1080/1040841X.2021.1921696 10.1021/acsami.2c05979 10.1038/nrmicro821 10.1111/j.1462-2920.2010.02308.x 10.1039/C5RA20856D 10.1007/s00253-022-12347-6 10.1590/S1517-83822012000300013 10.1039/C4NR04970E 10.1016/j.micpath.2016.06.016 10.3389/fmicb.2016.01366 10.1016/j.colsurfb.2021.112307 10.1038/s41522-022-00327-7 10.3389/fcimb.2021.656984 10.1046/j.1472-765X.1997.00378.x 10.1016/j.micpath.2022.105678 10.1099/jmm.0.45969-0 10.1038/s41579-018-0141-x |
ContentType | Journal Article |
Copyright | 2024 The Author(s) 2024 The Author(s). 2024 The Author(s) 2024 |
Copyright_xml | – notice: 2024 The Author(s) – notice: 2024 The Author(s). – notice: 2024 The Author(s) 2024 |
DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1016/j.bioflm.2024.100192 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2590-2075 |
EndPage | 100192 |
ExternalDocumentID | oai_doaj_org_article_1f795f0e3c8b4c0fbcd0d6501362d9de 10_1016_j_bioflm_2024_100192 38544742 S2590207524000170 |
Genre | Journal Article |
GroupedDBID | 0SF 6I. AAEDW AAFTH AALRI AAXUO AEXQZ AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS EJD FDB GROUPED_DOAJ M41 NCXOZ OK1 ROL RPM ADVLN AFJKZ NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c530t-d3b0a98b36272beceaf62c1ca122c4f4fc6b700c117c4438d876cd65147b89663 |
IEDL.DBID | RPM |
ISSN | 2590-2075 |
IngestDate | Tue Oct 22 15:15:14 EDT 2024 Tue Sep 17 21:29:24 EDT 2024 Sat Oct 26 05:54:05 EDT 2024 Thu Sep 26 18:03:39 EDT 2024 Sat Nov 02 12:15:32 EDT 2024 Wed Jun 26 17:51:35 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Antivirulence Antibiofilm Pyoverdine Silver nanoparticles Host-mimicking media |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. 2024 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c530t-d3b0a98b36272beceaf62c1ca122c4f4fc6b700c117c4438d876cd65147b89663 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-4902-3188 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10966193/ |
PMID | 38544742 |
PQID | 3014005092 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1f795f0e3c8b4c0fbcd0d6501362d9de pubmedcentral_primary_oai_pubmedcentral_nih_gov_10966193 proquest_miscellaneous_3014005092 crossref_primary_10_1016_j_bioflm_2024_100192 pubmed_primary_38544742 elsevier_sciencedirect_doi_10_1016_j_bioflm_2024_100192 |
PublicationCentury | 2000 |
PublicationDate | 2024-06-01 |
PublicationDateYYYYMMDD | 2024-06-01 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biofilm |
PublicationTitleAlternate | Biofilm |
PublicationYear | 2024 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Benedict (bib4) 2019; 68 Khan (bib62) 2020; 46 Brooks, Keevil (bib44) 1997; 24 Kim (bib72) 2014; 6 Larsson, Flach (bib1) 2022; 20 Tuon (bib88) 2022; 11 Stewart (bib76) 2002; 292 Baldan (bib13) 2014; 9 Singh, Mijakovic (bib32) 2022; 10 Kumar (bib60) 2017; 307 Highmore (bib61) 2022; 8 Tyers, Wright (bib81) 2019; 17 Asokan (bib7) 2019; 34 Kang (bib48) 2022; 11 Jeong (bib65) 2023 Liu (bib23) 2016; 7 Mohamed (bib86) 2020; 26 Jeong (bib78) 2023 Murray (bib6) 2022; 399 Who (bib9) October 2022 Who (bib8) March 2017 Tabassum (bib29) 2023; 21 Vanitha (bib70) 2017; 669 Sharma (bib73) 2021; 7 Garcia Maset (bib12) 2022; 14 Dragoš, Kovács (bib59) 2017; 25 Naik, Dubey (bib68) 2011; 62 Sharma, Misba, Khan (bib22) 2019; 8 Tabassum (bib46) 2023 Qin (bib87) 2022; 7 Jeong (bib41) 2023 Khorsandi (bib28) 2021; 19 Kumar, Paliya, Singh (bib89) 2022; 170 Khan (bib49) 2022; 211 Rather, Gupta, Mandal (bib66) 2021; 269 Jeong (bib64) 2023 Tamma, Cosgrove, Maragakis (bib80) 2012; 25 Khan (bib45) 2021; 19 Kumar (bib82) 2010; 38 Dutt (bib25) 2023; 21 Hall-Stoodley, Costerton, Stoodley (bib20) 2004; 2 Khan (bib84) 2021; 47 Du (bib74) 2017; 7 Flemming, Wingender (bib58) 2010; 8 Kyaw, Lim (bib83) 2012; 43 Di Martino (bib19) 2018; 4 Luo (bib56) 2017; 12 Hannauer (bib67) 2012; 586 Indira (bib38) 2019; 9 Oura (bib55) 2015; 81 Saravanan (bib37) 2021; 264 J (bib43) 2017; 68 Jebril, Jenana, Dridi (bib71) 2020; 248 Khan (bib30) 2023; 12 Khan (bib47) 2019; 17 Gold (bib5) 2022; 76 Furiga (bib51) 2015; 60 Sriramulu (bib42) 2005; 54 Rani (bib40) 2021; 26 Rather, Gupta, Mandal (bib18) 2021; 52 Saeki (bib79) 2021; 11 Lee (bib53) 2014; 169 Ahamad (bib77) 2022; 12 Fisher (bib3) 2022; 20 Rather (bib21) 2021; 61 Khan (bib50) 2020; 104 Dane (bib33) 2016; 6 Jeong (bib63) 2023 Ciofu (bib17) 2022; 20 Singh (bib31) 2018; 46 Abdelghani (bib39) 2021; 203 Schmittgen, Livak (bib57) 2008; 3 Rather (bib26) 2022; 300 Ali (bib36) 2019; 159 Khan (bib85) 2023; 53 Kumari, Barsainya, Singh (bib69) 2017; 24 Orazi, Jean-Pierre, O'Toole (bib14) 2020 Jeong (bib34) 2022; 20 Fu (bib52) 2017; 2017 Briaud (bib15) 2019; 9 Nadeem (bib35) 2022; 12 Ahmed (bib75) 2016; 98 O'Brien, Figueroa, Welch (bib16) 2022; 16 Kang (bib27) 2023 Lee, Cho, Lee (bib54) 2011; 13 Ersoy (bib11) 2017; 20 Khan (bib24) 2022; 14 Gow (bib2) 2022; 13 Humphries (bib10) 2018; 56 Vanitha (10.1016/j.bioflm.2024.100192_bib70) 2017; 669 Rather (10.1016/j.bioflm.2024.100192_bib18) 2021; 52 Hall-Stoodley (10.1016/j.bioflm.2024.100192_bib20) 2004; 2 Dragoš (10.1016/j.bioflm.2024.100192_bib59) 2017; 25 Ahmed (10.1016/j.bioflm.2024.100192_bib75) 2016; 98 Khan (10.1016/j.bioflm.2024.100192_bib84) 2021; 47 Ciofu (10.1016/j.bioflm.2024.100192_bib17) 2022; 20 Abdelghani (10.1016/j.bioflm.2024.100192_bib39) 2021; 203 Schmittgen (10.1016/j.bioflm.2024.100192_bib57) 2008; 3 Lee (10.1016/j.bioflm.2024.100192_bib53) 2014; 169 Humphries (10.1016/j.bioflm.2024.100192_bib10) 2018; 56 Rather (10.1016/j.bioflm.2024.100192_bib26) 2022; 300 Ali (10.1016/j.bioflm.2024.100192_bib36) 2019; 159 Jeong (10.1016/j.bioflm.2024.100192_bib65) 2023 Gold (10.1016/j.bioflm.2024.100192_bib5) 2022; 76 Dutt (10.1016/j.bioflm.2024.100192_bib25) 2023; 21 Kim (10.1016/j.bioflm.2024.100192_bib72) 2014; 6 Nadeem (10.1016/j.bioflm.2024.100192_bib35) 2022; 12 Jebril (10.1016/j.bioflm.2024.100192_bib71) 2020; 248 Sharma (10.1016/j.bioflm.2024.100192_bib73) 2021; 7 Di Martino (10.1016/j.bioflm.2024.100192_bib19) 2018; 4 Jeong (10.1016/j.bioflm.2024.100192_bib78) 2023 Khan (10.1016/j.bioflm.2024.100192_bib85) 2023; 53 J (10.1016/j.bioflm.2024.100192_bib43) 2017; 68 Khan (10.1016/j.bioflm.2024.100192_bib49) 2022; 211 Ahamad (10.1016/j.bioflm.2024.100192_bib77) 2022; 12 Sharma (10.1016/j.bioflm.2024.100192_bib22) 2019; 8 Kyaw (10.1016/j.bioflm.2024.100192_bib83) 2012; 43 Ersoy (10.1016/j.bioflm.2024.100192_bib11) 2017; 20 Kang (10.1016/j.bioflm.2024.100192_bib48) 2022; 11 Singh (10.1016/j.bioflm.2024.100192_bib31) 2018; 46 Jeong (10.1016/j.bioflm.2024.100192_bib41) 2023 Indira (10.1016/j.bioflm.2024.100192_bib38) 2019; 9 Qin (10.1016/j.bioflm.2024.100192_bib87) 2022; 7 Brooks (10.1016/j.bioflm.2024.100192_bib44) 1997; 24 Tamma (10.1016/j.bioflm.2024.100192_bib80) 2012; 25 Mohamed (10.1016/j.bioflm.2024.100192_bib86) 2020; 26 Khan (10.1016/j.bioflm.2024.100192_bib30) 2023; 12 Lee (10.1016/j.bioflm.2024.100192_bib54) 2011; 13 Who (10.1016/j.bioflm.2024.100192_bib8) 2017 Briaud (10.1016/j.bioflm.2024.100192_bib15) 2019; 9 O'Brien (10.1016/j.bioflm.2024.100192_bib16) 2022; 16 Luo (10.1016/j.bioflm.2024.100192_bib56) 2017; 12 Khan (10.1016/j.bioflm.2024.100192_bib24) 2022; 14 Oura (10.1016/j.bioflm.2024.100192_bib55) 2015; 81 Jeong (10.1016/j.bioflm.2024.100192_bib64) 2023 Sriramulu (10.1016/j.bioflm.2024.100192_bib42) 2005; 54 Murray (10.1016/j.bioflm.2024.100192_bib6) 2022; 399 Larsson (10.1016/j.bioflm.2024.100192_bib1) 2022; 20 Fisher (10.1016/j.bioflm.2024.100192_bib3) 2022; 20 Rather (10.1016/j.bioflm.2024.100192_bib21) 2021; 61 Kumar (10.1016/j.bioflm.2024.100192_bib60) 2017; 307 Asokan (10.1016/j.bioflm.2024.100192_bib7) 2019; 34 Singh (10.1016/j.bioflm.2024.100192_bib32) 2022; 10 Khan (10.1016/j.bioflm.2024.100192_bib47) 2019; 17 Tuon (10.1016/j.bioflm.2024.100192_bib88) 2022; 11 Gow (10.1016/j.bioflm.2024.100192_bib2) 2022; 13 Garcia Maset (10.1016/j.bioflm.2024.100192_bib12) 2022; 14 Hannauer (10.1016/j.bioflm.2024.100192_bib67) 2012; 586 Khan (10.1016/j.bioflm.2024.100192_bib50) 2020; 104 Kumari (10.1016/j.bioflm.2024.100192_bib69) 2017; 24 Jeong (10.1016/j.bioflm.2024.100192_bib34) 2022; 20 Highmore (10.1016/j.bioflm.2024.100192_bib61) 2022; 8 Tyers (10.1016/j.bioflm.2024.100192_bib81) 2019; 17 Baldan (10.1016/j.bioflm.2024.100192_bib13) 2014; 9 Who (10.1016/j.bioflm.2024.100192_bib9) 2022 Fu (10.1016/j.bioflm.2024.100192_bib52) 2017; 2017 Jeong (10.1016/j.bioflm.2024.100192_bib63) 2023 Saravanan (10.1016/j.bioflm.2024.100192_bib37) 2021; 264 Kumar (10.1016/j.bioflm.2024.100192_bib89) 2022; 170 Liu (10.1016/j.bioflm.2024.100192_bib23) 2016; 7 Furiga (10.1016/j.bioflm.2024.100192_bib51) 2015; 60 Tabassum (10.1016/j.bioflm.2024.100192_bib46) 2023 Tabassum (10.1016/j.bioflm.2024.100192_bib29) 2023; 21 Rather (10.1016/j.bioflm.2024.100192_bib66) 2021; 269 Benedict (10.1016/j.bioflm.2024.100192_bib4) 2019; 68 Kang (10.1016/j.bioflm.2024.100192_bib27) 2023 Khan (10.1016/j.bioflm.2024.100192_bib45) 2021; 19 Flemming (10.1016/j.bioflm.2024.100192_bib58) 2010; 8 Rani (10.1016/j.bioflm.2024.100192_bib40) 2021; 26 Stewart (10.1016/j.bioflm.2024.100192_bib76) 2002; 292 Saeki (10.1016/j.bioflm.2024.100192_bib79) 2021; 11 Kumar (10.1016/j.bioflm.2024.100192_bib82) 2010; 38 Dane (10.1016/j.bioflm.2024.100192_bib33) 2016; 6 Du (10.1016/j.bioflm.2024.100192_bib74) 2017; 7 Khan (10.1016/j.bioflm.2024.100192_bib62) 2020; 46 Orazi (10.1016/j.bioflm.2024.100192_bib14) 2020 Khorsandi (10.1016/j.bioflm.2024.100192_bib28) 2021; 19 Naik (10.1016/j.bioflm.2024.100192_bib68) 2011; 62 |
References_xml | – volume: 68 start-page: 1791 year: 2019 end-page: 1797 ident: bib4 article-title: Estimation of direct healthcare costs of fungal diseases in the United States publication-title: Clin Infect Dis contributor: fullname: Benedict – volume: 46 start-page: 665 year: 2020 end-page: 688 ident: bib62 article-title: Treatment strategies targeting persister cell formation in bacterial pathogens publication-title: Crit Rev Microbiol contributor: fullname: Khan – volume: 38 start-page: 1651 year: 2010 end-page: 1664 ident: bib82 article-title: A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study publication-title: Crit Care Med contributor: fullname: Kumar – volume: 2 start-page: 95 year: 2004 end-page: 108 ident: bib20 article-title: Bacterial biofilms: from the natural environment to infectious diseases publication-title: Nat Rev Microbiol contributor: fullname: Stoodley – volume: 17 year: 2019 ident: bib47 article-title: Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in publication-title: Mar Drugs contributor: fullname: Khan – volume: 6 start-page: 4180 year: 2014 end-page: 14184 ident: bib72 article-title: Suppression of nanoparticle cytotoxicity approaching publication-title: Nanoscale contributor: fullname: Kim – volume: 24 start-page: 4645 year: 2017 end-page: 4654 ident: bib69 article-title: Biogenic synthesis of silver nanoparticle by using secondary metabolites from publication-title: Environ Sci Pollut Res contributor: fullname: Singh – volume: 34 start-page: 184 year: 2019 end-page: 193 ident: bib7 article-title: WHO global priority pathogens list: a bibliometric analysis of medline-pubMed for knowledge mobilization to infection prevention and control practices in Bahrain publication-title: Oman Med J contributor: fullname: Asokan – volume: 19 start-page: 601 year: 2021 ident: bib45 article-title: Phloroglucinol-gold and -zinc oxide nanoparticles: antibiofilm and antivirulence activities towards publication-title: Mar Drugs contributor: fullname: Khan – volume: 20 start-page: 173 year: 2017 end-page: 181 ident: bib11 article-title: Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing publication-title: EBioMedicine contributor: fullname: Ersoy – volume: 20 start-page: 557 year: 2022 end-page: 571 ident: bib3 article-title: Tackling the emerging threat of antifungal resistance to human health publication-title: Nat Rev Microbiol contributor: fullname: Fisher – volume: 586 start-page: 96 year: 2012 end-page: 101 ident: bib67 article-title: Biosynthesis of the pyoverdine siderophore of publication-title: FEBS Lett contributor: fullname: Hannauer – volume: 19 start-page: 1299 year: 2021 end-page: 1323 ident: bib28 article-title: Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities publication-title: Expert Rev Anti Infect Ther contributor: fullname: Khorsandi – volume: 21 start-page: 148 year: 2023 ident: bib25 article-title: Therapeutic applications of nanobiotechnology publication-title: J Nanobiotechnol contributor: fullname: Dutt – volume: 8 start-page: 623 year: 2010 end-page: 633 ident: bib58 article-title: The biofilm matrix publication-title: Nat Rev Microbiol contributor: fullname: Wingender – volume: 98 start-page: 50 year: 2016 end-page: 56 ident: bib75 article-title: Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against publication-title: Microb Pathog contributor: fullname: Ahmed – volume: 46 start-page: 886 year: 2018 end-page: 899 ident: bib31 article-title: Anti-biofilm effects of gold and silver nanoparticles synthesized by the publication-title: Artif Cells Nanomed Biotechnol contributor: fullname: Singh – volume: 170 year: 2022 ident: bib89 article-title: Superior inhibition of virulence and biofilm formation of publication-title: Microb Pathog contributor: fullname: Singh – volume: 8 start-page: 68 year: 2022 ident: bib61 article-title: Translational challenges and opportunities in biofilm science: a BRIEF for the future publication-title: NPJ Biofilms Microbiomes contributor: fullname: Highmore – volume: 20 start-page: 257 year: 2022 end-page: 269 ident: bib1 article-title: Antibiotic resistance in the environment publication-title: Nat Rev Microbiol contributor: fullname: Flach – year: October 2022 ident: bib9 article-title: WHO fungal priority pathogens list to guide research, development and public health action contributor: fullname: Who – volume: 13 start-page: 62 year: 2011 end-page: 73 ident: bib54 article-title: 3-indolylacetonitrile decreases publication-title: Environ Microbiol contributor: fullname: Lee – volume: 21 year: 2023 ident: bib29 article-title: Inhibition of polymicrobial biofilms of publication-title: Mar Drugs contributor: fullname: Tabassum – volume: 9 year: 2014 ident: bib13 article-title: Adaptation of publication-title: PLoS One contributor: fullname: Baldan – volume: 26 start-page: 1142 year: 2021 ident: bib40 article-title: Microorganisms: a potential source of bioactive molecules for antioxidant applications publication-title: Molecules contributor: fullname: Rani – year: 2023 ident: bib41 article-title: virulence attenuation by inhibiting siderophore functions publication-title: Appl Microbiol Biotechnol contributor: fullname: Jeong – year: 2023 ident: bib64 article-title: pH-responsive polymeric nanomaterials for the treatment of oral biofilm infections publication-title: Colloids Surf B Biointerfaces contributor: fullname: Jeong – volume: 3 start-page: 1101 year: 2008 end-page: 1108 ident: bib57 article-title: Analyzing real-time PCR data by the comparative C(T) method publication-title: Nat Protoc contributor: fullname: Livak – volume: 248 year: 2020 ident: bib71 article-title: Green synthesis of silver nanoparticles using publication-title: Mater Chem Phys contributor: fullname: Dridi – volume: 14 start-page: 32855 year: 2022 end-page: 32868 ident: bib12 article-title: Evaluation of the antimicrobial activity in host-mimicking media and publication-title: ACS Appl Mater Interfaces contributor: fullname: Garcia Maset – volume: 264 year: 2021 ident: bib37 article-title: A review on biosynthesis of metal nanoparticles and its environmental applications publication-title: Chemosphere contributor: fullname: Saravanan – volume: 20 start-page: 621 year: 2022 end-page: 635 ident: bib17 article-title: Tolerance and resistance of microbial biofilms publication-title: Nat Rev Microbiol contributor: fullname: Ciofu – volume: 9 year: 2019 ident: bib15 article-title: Coexistence with publication-title: Sci Rep contributor: fullname: Briaud – volume: 52 start-page: 1701 year: 2021 end-page: 1718 ident: bib18 article-title: Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies publication-title: Braz J Microbiol contributor: fullname: Mandal – volume: 13 start-page: 5352 year: 2022 ident: bib2 article-title: The importance of antimicrobial resistance in medical mycology publication-title: Nat Commun contributor: fullname: Gow – year: March 2017 ident: bib8 article-title: WHO publishes list of bacteria for which new antibiotics are urgently needed contributor: fullname: Who – volume: 14 start-page: 14824 year: 2022 end-page: 14857 ident: bib24 article-title: Retrospective analysis of the key molecules involved in the green synthesis of nanoparticles publication-title: Nanoscale contributor: fullname: Khan – year: 2023 ident: bib27 article-title: Inhibition of biofilm and virulence properties of pathogenic bacteria by silver and gold nanoparticles synthesized from publication-title: ACS Omega contributor: fullname: Kang – volume: 10 start-page: 628 year: 2022 ident: bib32 article-title: Antibacterial effect of silver nanoparticles is stronger if the production host and the targeted pathogen are closely related publication-title: Biomedicines contributor: fullname: Mijakovic – volume: 81 start-page: 2808 year: 2015 end-page: 2818 ident: bib55 article-title: Inhibition of publication-title: Appl Environ Microbiol contributor: fullname: Oura – volume: 7 year: 2016 ident: bib23 article-title: Interspecific bacterial interactions are reflected in multispecies biofilm spatial organization publication-title: Front Microbiol contributor: fullname: Liu – volume: 54 start-page: 667 year: 2005 end-page: 676 ident: bib42 article-title: Microcolony formation: a novel biofilm model of publication-title: J Med Microbiol contributor: fullname: Sriramulu – volume: 7 start-page: 41 year: 2017 ident: bib74 article-title: Human salivary protein histatin 5 has potent bactericidal activity against ESKAPE pathogens publication-title: Front Cell Infect Microbiol contributor: fullname: Du – volume: 62 start-page: 409 year: 2011 end-page: 414 ident: bib68 article-title: Lead-enhanced siderophore production and alteration in cell morphology in a Pb-resistant publication-title: Curr Microbiol contributor: fullname: Dubey – volume: 203 start-page: 4755 year: 2021 end-page: 4776 ident: bib39 article-title: Therapeutic applications and biological activities of bacterial bioactive extracts publication-title: Arch Microbiol contributor: fullname: Abdelghani – volume: 12 year: 2022 ident: bib77 article-title: Antibiofilm activities of biogenic silver nanoparticles against publication-title: Front Microbiol contributor: fullname: Ahamad – volume: 169 start-page: 888 year: 2014 end-page: 896 ident: bib53 article-title: ZnO nanoparticles inhibit publication-title: Microbiol Res contributor: fullname: Lee – volume: 11 start-page: 1524 year: 2022 ident: bib48 article-title: Antibiofilm and antivirulence activities of gold and zinc oxide nanoparticles synthesized from Kimchi-isolated publication-title: Antibiotics contributor: fullname: Kang – year: 2023 ident: bib63 article-title: Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid publication-title: Int J Antimicrob Agents contributor: fullname: Jeong – start-page: 1 year: 2023 end-page: 29 ident: bib78 article-title: Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in publication-title: Crit Rev Microbiol contributor: fullname: Jeong – volume: 9 start-page: 306 year: 2019 ident: bib38 article-title: Bioactive molecules of probiotic bacteria and their mechanism of action: a review publication-title: 3 Biotech contributor: fullname: Indira – volume: 12 year: 2023 ident: bib30 article-title: Inhibition of mixed biofilms of publication-title: Antibiotics contributor: fullname: Khan – volume: 11 year: 2022 ident: bib88 article-title: Pathogenesis of the publication-title: Pathogens contributor: fullname: Tuon – volume: 17 start-page: 141 year: 2019 end-page: 155 ident: bib81 article-title: Drug combinations: a strategy to extend the life of antibiotics in the 21st century publication-title: Nat Rev Microbiol contributor: fullname: Wright – volume: 43 start-page: 938 year: 2012 end-page: 945 ident: bib83 article-title: Bactericidal antibiotic-phytochemical combinations against methicillin resistant publication-title: Braz J Microbiol contributor: fullname: Lim – volume: 7 start-page: 199 year: 2022 ident: bib87 article-title: : pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics publication-title: Signal Transduct Targeted Ther contributor: fullname: Qin – volume: 12 start-page: 130 year: 2022 ident: bib35 article-title: A review of microbial mediated iron nanoparticles (IONPs) and its biomedical applications publication-title: Nanomaterials contributor: fullname: Nadeem – volume: 76 start-page: 255 year: 2022 end-page: 262 ident: bib5 article-title: Increased deaths from fungal infections during the coronavirus disease 2019 pandemic—national vital statistics system, United States, January 2020–December 2021 publication-title: Clin Infect Dis contributor: fullname: Gold – volume: 8 start-page: 76 year: 2019 ident: bib22 article-title: Antibiotics versus biofilm: an emerging battleground in microbial communities publication-title: Antimicrob Resist Infect Control contributor: fullname: Khan – start-page: 202 year: 2020 ident: bib14 article-title: PA14 enhances the efficacy of norfloxacin against publication-title: J Bacteriol contributor: fullname: O'Toole – year: 2023 ident: bib65 article-title: Alteration of oral microbial biofilms by sweeteners publication-title: Biofilms contributor: fullname: Jeong – volume: 25 start-page: 257 year: 2017 end-page: 266 ident: bib59 article-title: The peculiar functions of the bacterial extracellular matrix publication-title: Trends Microbiol contributor: fullname: Kovács – volume: 20 start-page: 527 year: 2022 ident: bib34 article-title: Marine-bioinspired nanoparticles as potential drugs for multiple biological roles publication-title: Mar Drugs contributor: fullname: Jeong – volume: 68 start-page: 807 year: 2017 end-page: 813 ident: bib43 article-title: Artificial saliva and its use in biological experiments publication-title: J Physiol Pharmacol contributor: fullname: J – volume: 6 start-page: 8503 year: 2016 end-page: 8510 ident: bib33 article-title: Pyoverdin mediated sunlight induced green synthesis of silver nanoparticles publication-title: RSC Adv contributor: fullname: Dane – volume: 269 year: 2021 ident: bib66 article-title: Inhibition of biofilm and quorum sensing-regulated virulence factors in publication-title: J Ethnopharmacol contributor: fullname: Mandal – volume: 211 year: 2022 ident: bib49 article-title: Inhibitory activities of phloroglucinol-chitosan nanoparticles on mono- and dual-species biofilms of publication-title: Colloids Surf B Biointerfaces contributor: fullname: Khan – volume: 399 start-page: 629 year: 2022 end-page: 655 ident: bib6 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet contributor: fullname: Murray – volume: 25 start-page: 450 year: 2012 end-page: 470 ident: bib80 article-title: Combination therapy for treatment of infections with Gram-negative bacteria publication-title: Clin Microbiol Rev contributor: fullname: Maragakis – volume: 16 start-page: 1694 year: 2022 end-page: 1704 ident: bib16 article-title: Decreased efficacy of antimicrobial agents in a polymicrobial environment publication-title: ISME J contributor: fullname: Welch – volume: 56 year: 2018 ident: bib10 article-title: CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests publication-title: J Clin Microbiol contributor: fullname: Humphries – volume: 24 start-page: 203 year: 1997 end-page: 206 ident: bib44 article-title: A simple artificial urine for the growth of urinary pathogens publication-title: Lett Appl Microbiol contributor: fullname: Keevil – volume: 60 start-page: 1676 year: 2015 end-page: 1686 ident: bib51 article-title: Impairment of publication-title: Antimicrob Agents Chemother contributor: fullname: Furiga – volume: 12 year: 2017 ident: bib56 article-title: Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances publication-title: PLoS One contributor: fullname: Luo – volume: 292 start-page: 107 year: 2002 end-page: 113 ident: bib76 article-title: Mechanisms of antibiotic resistance in bacterial biofilms publication-title: Int J Med Microbiol contributor: fullname: Stewart – volume: 47 start-page: 699 year: 2021 end-page: 727 ident: bib84 article-title: Mixed biofilms of pathogenic publication-title: Crit Rev Microbiol contributor: fullname: Khan – volume: 53 start-page: 115 year: 2023 end-page: 136 ident: bib85 article-title: Surface adherence and vacuolar internalization of bacterial pathogens to the publication-title: J Adv Res contributor: fullname: Khan – volume: 159 start-page: 18 year: 2019 end-page: 25 ident: bib36 article-title: Revisiting the mechanistic pathways for bacterial mediated synthesis of noble metal nanoparticles publication-title: J Microbiol Methods contributor: fullname: Ali – year: 2023 ident: bib46 article-title: Treatment of publication-title: Microb Pathog contributor: fullname: Tabassum – volume: 300 year: 2022 ident: bib26 article-title: Ecofriendly phytofabrication of silver nanoparticles using aqueous extract of publication-title: Chemosphere contributor: fullname: Rather – volume: 4 start-page: 274 year: 2018 end-page: 288 ident: bib19 article-title: Extracellular polymeric substances, a key element in understanding biofilm phenotype publication-title: AIMS Microbiol contributor: fullname: Di Martino – volume: 26 start-page: 1410 year: 2020 end-page: 1420 ident: bib86 article-title: Combination of silver nanoparticles and vancomycin to overcome antibiotic resistance in planktonic/biofilm cell from clinical and animal source publication-title: Microb Drug Resist contributor: fullname: Mohamed – volume: 307 start-page: 481 year: 2017 end-page: 489 ident: bib60 article-title: Biofilms: survival and defense strategy for pathogens publication-title: Int J Med Microbiol contributor: fullname: Kumar – volume: 2017 year: 2017 ident: bib52 article-title: Inhibition of publication-title: BioMed Res Int contributor: fullname: Fu – volume: 104 start-page: 799 year: 2020 end-page: 816 ident: bib50 article-title: Streptomycin mediated biofilm inhibition and suppression of virulence properties in publication-title: Appl Microbiol Biotechnol contributor: fullname: Khan – volume: 669 start-page: 71 year: 2017 end-page: 79 ident: bib70 article-title: Physiochemical charge stabilization of silver nanoparticles and its antibacterial applications publication-title: Chem Phys Lett contributor: fullname: Vanitha – volume: 7 year: 2021 ident: bib73 article-title: Envisaging antifungal potential of histatin 5: a physiological salivary peptide publication-title: J Fungi contributor: fullname: Sharma – volume: 11 year: 2021 ident: bib79 article-title: Subinhibitory concentrations of biogenic silver nanoparticles affect motility and biofilm formation in publication-title: Front Cell Infect Microbiol contributor: fullname: Saeki – volume: 61 start-page: 380 year: 2021 end-page: 395 ident: bib21 article-title: Microbial biofilm: a matter of grave concern for human health and food industry publication-title: J Basic Microbiol contributor: fullname: Rather – volume: 11 start-page: 1524 issue: 11 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib48 article-title: Antibiofilm and antivirulence activities of gold and zinc oxide nanoparticles synthesized from Kimchi-isolated Leuconostoc sp. strain C2 publication-title: Antibiotics doi: 10.3390/antibiotics11111524 contributor: fullname: Kang – volume: 76 start-page: 255 issue: 3 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib5 article-title: Increased deaths from fungal infections during the coronavirus disease 2019 pandemic—national vital statistics system, United States, January 2020–December 2021 publication-title: Clin Infect Dis doi: 10.1093/cid/ciac489 contributor: fullname: Gold – volume: 61 start-page: 380 issue: 5 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib21 article-title: Microbial biofilm: a matter of grave concern for human health and food industry publication-title: J Basic Microbiol doi: 10.1002/jobm.202000678 contributor: fullname: Rather – volume: 9 issue: 3 year: 2014 ident: 10.1016/j.bioflm.2024.100192_bib13 article-title: Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection publication-title: PLoS One doi: 10.1371/journal.pone.0089614 contributor: fullname: Baldan – volume: 56 issue: 4 year: 2018 ident: 10.1016/j.bioflm.2024.100192_bib10 article-title: CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests publication-title: J Clin Microbiol doi: 10.1128/JCM.01934-17 contributor: fullname: Humphries – volume: 203 start-page: 4755 issue: 8 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib39 article-title: Therapeutic applications and biological activities of bacterial bioactive extracts publication-title: Arch Microbiol doi: 10.1007/s00203-021-02505-1 contributor: fullname: Abdelghani – volume: 52 start-page: 1701 issue: 4 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib18 article-title: Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies publication-title: Braz J Microbiol doi: 10.1007/s42770-021-00624-x contributor: fullname: Rather – volume: 12 issue: 4 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib56 article-title: Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model publication-title: PLoS One doi: 10.1371/journal.pone.0176883 contributor: fullname: Luo – volume: 248 year: 2020 ident: 10.1016/j.bioflm.2024.100192_bib71 article-title: Green synthesis of silver nanoparticles using Melia azedarach leaf extract and their antifungal activities: in vitro and in vivo publication-title: Mater Chem Phys doi: 10.1016/j.matchemphys.2020.122898 contributor: fullname: Jebril – volume: 46 start-page: 886 issue: 3 year: 2018 ident: 10.1016/j.bioflm.2024.100192_bib31 article-title: Anti-biofilm effects of gold and silver nanoparticles synthesized by the Rhodiola rosea rhizome extracts publication-title: Artif Cells Nanomed Biotechnol doi: 10.1080/21691401.2018.1518909 contributor: fullname: Singh – volume: 20 start-page: 173 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib11 article-title: Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing publication-title: EBioMedicine doi: 10.1016/j.ebiom.2017.05.026 contributor: fullname: Ersoy – volume: 20 start-page: 527 issue: 8 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib34 article-title: Marine-bioinspired nanoparticles as potential drugs for multiple biological roles publication-title: Mar Drugs doi: 10.3390/md20080527 contributor: fullname: Jeong – volume: 8 start-page: 623 issue: 9 year: 2010 ident: 10.1016/j.bioflm.2024.100192_bib58 article-title: The biofilm matrix publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro2415 contributor: fullname: Flemming – volume: 19 start-page: 1299 issue: 10 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib28 article-title: Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities publication-title: Expert Rev Anti Infect Ther doi: 10.1080/14787210.2021.1908125 contributor: fullname: Khorsandi – volume: 38 start-page: 1651 issue: 8 year: 2010 ident: 10.1016/j.bioflm.2024.100192_bib82 article-title: A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181e96b91 contributor: fullname: Kumar – start-page: 1 year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib78 article-title: Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa publication-title: Crit Rev Microbiol doi: 10.1080/1040841X.2023.2282459 contributor: fullname: Jeong – volume: 159 start-page: 18 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib36 article-title: Revisiting the mechanistic pathways for bacterial mediated synthesis of noble metal nanoparticles publication-title: J Microbiol Methods doi: 10.1016/j.mimet.2019.02.010 contributor: fullname: Ali – volume: 24 start-page: 4645 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib69 article-title: Biogenic synthesis of silver nanoparticle by using secondary metabolites from Pseudomonas aeruginosa DM1 and its anti-algal effect on Chlorella vulgaris and Chlorella pyrenoidosa publication-title: Environ Sci Pollut Res doi: 10.1007/s11356-016-8170-3 contributor: fullname: Kumari – volume: 399 start-page: 629 issue: 10325 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib6 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(21)02724-0 contributor: fullname: Murray – volume: 8 start-page: 76 issue: 1 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib22 article-title: Antibiotics versus biofilm: an emerging battleground in microbial communities publication-title: Antimicrob Resist Infect Control doi: 10.1186/s13756-019-0533-3 contributor: fullname: Sharma – volume: 586 start-page: 96 issue: 1 year: 2012 ident: 10.1016/j.bioflm.2024.100192_bib67 article-title: Biosynthesis of the pyoverdine siderophore of Pseudomonas aeruginosa involves precursors with a myristic or a myristoleic acid chain publication-title: FEBS Lett doi: 10.1016/j.febslet.2011.12.004 contributor: fullname: Hannauer – volume: 669 start-page: 71 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib70 article-title: Physiochemical charge stabilization of silver nanoparticles and its antibacterial applications publication-title: Chem Phys Lett doi: 10.1016/j.cplett.2016.11.037 contributor: fullname: Vanitha – volume: 7 issue: 12 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib73 article-title: Envisaging antifungal potential of histatin 5: a physiological salivary peptide publication-title: J Fungi doi: 10.3390/jof7121070 contributor: fullname: Sharma – volume: 68 start-page: 807 issue: 6 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib43 article-title: Artificial saliva and its use in biological experiments publication-title: J Physiol Pharmacol contributor: fullname: J – volume: 269 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib66 article-title: Inhibition of biofilm and quorum sensing-regulated virulence factors in Pseudomonas aeruginosa by Cuphea carthagenensis (Jacq.) J. F. Macbr. leaf extract: an in vitro study publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2020.113699 contributor: fullname: Rather – volume: 21 start-page: 148 issue: 1 year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib25 article-title: Therapeutic applications of nanobiotechnology publication-title: J Nanobiotechnol doi: 10.1186/s12951-023-01909-z contributor: fullname: Dutt – volume: 81 start-page: 2808 issue: 8 year: 2015 ident: 10.1016/j.bioflm.2024.100192_bib55 article-title: Inhibition of Pseudomonas aeruginosa swarming motility by 1-naphthol and other bicyclic compounds bearing hydroxyl groups publication-title: Appl Environ Microbiol doi: 10.1128/AEM.04220-14 contributor: fullname: Oura – volume: 10 start-page: 628 issue: 3 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib32 article-title: Antibacterial effect of silver nanoparticles is stronger if the production host and the targeted pathogen are closely related publication-title: Biomedicines doi: 10.3390/biomedicines10030628 contributor: fullname: Singh – volume: 3 start-page: 1101 issue: 6 year: 2008 ident: 10.1016/j.bioflm.2024.100192_bib57 article-title: Analyzing real-time PCR data by the comparative C(T) method publication-title: Nat Protoc doi: 10.1038/nprot.2008.73 contributor: fullname: Schmittgen – volume: 53 start-page: 115 year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib85 article-title: Surface adherence and vacuolar internalization of bacterial pathogens to the Candida spp. cells: mechanism of persistence and propagation publication-title: J Adv Res doi: 10.1016/j.jare.2022.12.013 contributor: fullname: Khan – volume: 46 start-page: 665 issue: 6 year: 2020 ident: 10.1016/j.bioflm.2024.100192_bib62 article-title: Treatment strategies targeting persister cell formation in bacterial pathogens publication-title: Crit Rev Microbiol doi: 10.1080/1040841X.2020.1822278 contributor: fullname: Khan – volume: 11 issue: 3 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib88 article-title: Pathogenesis of the Pseudomonas aeruginosa biofilm: a review publication-title: Pathogens doi: 10.3390/pathogens11030300 contributor: fullname: Tuon – volume: 68 start-page: 1791 issue: 11 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib4 article-title: Estimation of direct healthcare costs of fungal diseases in the United States publication-title: Clin Infect Dis doi: 10.1093/cid/ciy776 contributor: fullname: Benedict – volume: 25 start-page: 450 issue: 3 year: 2012 ident: 10.1016/j.bioflm.2024.100192_bib80 article-title: Combination therapy for treatment of infections with Gram-negative bacteria publication-title: Clin Microbiol Rev doi: 10.1128/CMR.05041-11 contributor: fullname: Tamma – volume: 9 issue: 1 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib15 article-title: Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells publication-title: Sci Rep doi: 10.1038/s41598-019-52975-z contributor: fullname: Briaud – year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib65 article-title: Alteration of oral microbial biofilms by sweeteners publication-title: Biofilms contributor: fullname: Jeong – volume: 62 start-page: 409 issue: 2 year: 2011 ident: 10.1016/j.bioflm.2024.100192_bib68 article-title: Lead-enhanced siderophore production and alteration in cell morphology in a Pb-resistant Pseudomonas aeruginosa strain 4EA publication-title: Curr Microbiol doi: 10.1007/s00284-010-9722-2 contributor: fullname: Naik – volume: 26 start-page: 1410 issue: 11 year: 2020 ident: 10.1016/j.bioflm.2024.100192_bib86 article-title: Combination of silver nanoparticles and vancomycin to overcome antibiotic resistance in planktonic/biofilm cell from clinical and animal source publication-title: Microb Drug Resist doi: 10.1089/mdr.2020.0089 contributor: fullname: Mohamed – volume: 300 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib26 article-title: Ecofriendly phytofabrication of silver nanoparticles using aqueous extract of Cuphea carthagenensis and their antioxidant potential and antibacterial activity against clinically important human pathogens publication-title: Chemosphere doi: 10.1016/j.chemosphere.2022.134497 contributor: fullname: Rather – volume: 7 start-page: 199 issue: 1 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib87 article-title: Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics publication-title: Signal Transduct Targeted Ther doi: 10.1038/s41392-022-01056-1 contributor: fullname: Qin – volume: 307 start-page: 481 issue: 8 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib60 article-title: Biofilms: survival and defense strategy for pathogens publication-title: Int J Med Microbiol doi: 10.1016/j.ijmm.2017.09.016 contributor: fullname: Kumar – year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib9 contributor: fullname: Who – year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib27 article-title: Inhibition of biofilm and virulence properties of pathogenic bacteria by silver and gold nanoparticles synthesized from Lactiplantibacillus sp. strain C1 publication-title: ACS Omega doi: 10.1021/acsomega.2c06789 contributor: fullname: Kang – volume: 9 start-page: 306 issue: 8 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib38 article-title: Bioactive molecules of probiotic bacteria and their mechanism of action: a review publication-title: 3 Biotech doi: 10.1007/s13205-019-1841-2 contributor: fullname: Indira – volume: 20 start-page: 621 issue: 10 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib17 article-title: Tolerance and resistance of microbial biofilms publication-title: Nat Rev Microbiol doi: 10.1038/s41579-022-00682-4 contributor: fullname: Ciofu – volume: 12 issue: 4 year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib30 article-title: Inhibition of mixed biofilms of Candida albicans and Staphylococcus aureus by β-caryophyllene-gold nanoparticles publication-title: Antibiotics doi: 10.3390/antibiotics12040726 contributor: fullname: Khan – volume: 7 start-page: 41 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib74 article-title: Human salivary protein histatin 5 has potent bactericidal activity against ESKAPE pathogens publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2017.00041 contributor: fullname: Du – start-page: 202 issue: 18 year: 2020 ident: 10.1016/j.bioflm.2024.100192_bib14 article-title: Pseudomonas aeruginosa PA14 enhances the efficacy of norfloxacin against Staphylococcus aureus newman biofilms publication-title: J Bacteriol contributor: fullname: Orazi – volume: 13 start-page: 5352 issue: 1 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib2 article-title: The importance of antimicrobial resistance in medical mycology publication-title: Nat Commun doi: 10.1038/s41467-022-32249-5 contributor: fullname: Gow – volume: 25 start-page: 257 issue: 4 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib59 article-title: The peculiar functions of the bacterial extracellular matrix publication-title: Trends Microbiol doi: 10.1016/j.tim.2016.12.010 contributor: fullname: Dragoš – volume: 292 start-page: 107 issue: 2 year: 2002 ident: 10.1016/j.bioflm.2024.100192_bib76 article-title: Mechanisms of antibiotic resistance in bacterial biofilms publication-title: Int J Med Microbiol doi: 10.1078/1438-4221-00196 contributor: fullname: Stewart – volume: 26 start-page: 1142 issue: 4 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib40 article-title: Microorganisms: a potential source of bioactive molecules for antioxidant applications publication-title: Molecules doi: 10.3390/molecules26041142 contributor: fullname: Rani – volume: 20 start-page: 557 issue: 9 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib3 article-title: Tackling the emerging threat of antifungal resistance to human health publication-title: Nat Rev Microbiol doi: 10.1038/s41579-022-00720-1 contributor: fullname: Fisher – volume: 34 start-page: 184 issue: 3 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib7 article-title: WHO global priority pathogens list: a bibliometric analysis of medline-pubMed for knowledge mobilization to infection prevention and control practices in Bahrain publication-title: Oman Med J doi: 10.5001/omj.2019.37 contributor: fullname: Asokan – year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib8 contributor: fullname: Who – volume: 264 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib37 article-title: A review on biosynthesis of metal nanoparticles and its environmental applications publication-title: Chemosphere doi: 10.1016/j.chemosphere.2020.128580 contributor: fullname: Saravanan – volume: 20 start-page: 257 issue: 5 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib1 article-title: Antibiotic resistance in the environment publication-title: Nat Rev Microbiol doi: 10.1038/s41579-021-00649-x contributor: fullname: Larsson – volume: 2017 year: 2017 ident: 10.1016/j.bioflm.2024.100192_bib52 article-title: Inhibition of Pseudomonas aeruginosa biofilm formation by traditional Chinese medicinal herb Herba patriniae publication-title: BioMed Res Int doi: 10.1155/2017/9584703 contributor: fullname: Fu – volume: 4 start-page: 274 issue: 2 year: 2018 ident: 10.1016/j.bioflm.2024.100192_bib19 article-title: Extracellular polymeric substances, a key element in understanding biofilm phenotype publication-title: AIMS Microbiol doi: 10.3934/microbiol.2018.2.274 contributor: fullname: Di Martino – volume: 169 start-page: 888 issue: 12 year: 2014 ident: 10.1016/j.bioflm.2024.100192_bib53 article-title: ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production publication-title: Microbiol Res doi: 10.1016/j.micres.2014.05.005 contributor: fullname: Lee – volume: 104 start-page: 799 issue: 2 year: 2020 ident: 10.1016/j.bioflm.2024.100192_bib50 article-title: Streptomycin mediated biofilm inhibition and suppression of virulence properties in Pseudomonas aeruginosa PAO1 publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-019-10190-w contributor: fullname: Khan – volume: 14 start-page: 14824 issue: 40 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib24 article-title: Retrospective analysis of the key molecules involved in the green synthesis of nanoparticles publication-title: Nanoscale doi: 10.1039/D2NR03632K contributor: fullname: Khan – volume: 21 issue: 2 year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib29 article-title: Inhibition of polymicrobial biofilms of Candida albicans-Staphylococcus aureus/Streptococcus mutans by fucoidan-gold nanoparticles publication-title: Mar Drugs doi: 10.3390/md21020123 contributor: fullname: Tabassum – volume: 60 start-page: 1676 issue: 3 year: 2015 ident: 10.1016/j.bioflm.2024.100192_bib51 article-title: Impairment of Pseudomonas aeruginosa biofilm resistance to antibiotics by combining the drugs with a new quorum-sensing inhibitor publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02533-15 contributor: fullname: Furiga – year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib63 article-title: Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2023.106941 contributor: fullname: Jeong – volume: 17 issue: 4 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib47 article-title: Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in Pseudomonas aeruginosa PAO1 publication-title: Mar Drugs doi: 10.3390/md17040208 contributor: fullname: Khan – volume: 19 start-page: 601 issue: 11 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib45 article-title: Phloroglucinol-gold and -zinc oxide nanoparticles: antibiofilm and antivirulence activities towards Pseudomonas aeruginosa PAO1 publication-title: Mar Drugs doi: 10.3390/md19110601 contributor: fullname: Khan – volume: 12 start-page: 130 issue: 1 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib35 article-title: A review of microbial mediated iron nanoparticles (IONPs) and its biomedical applications publication-title: Nanomaterials doi: 10.3390/nano12010130 contributor: fullname: Nadeem – volume: 12 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib77 article-title: Antibiofilm activities of biogenic silver nanoparticles against Candida albicans publication-title: Front Microbiol doi: 10.3389/fmicb.2021.741493 contributor: fullname: Ahamad – volume: 16 start-page: 1694 issue: 7 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib16 article-title: Decreased efficacy of antimicrobial agents in a polymicrobial environment publication-title: ISME J doi: 10.1038/s41396-022-01218-7 contributor: fullname: O'Brien – year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib46 article-title: Treatment of Staphylococcus aureus and Candida albicans polymicrobial biofilms by phloroglucinol-gold nanoparticles publication-title: Microb Pathog doi: 10.1016/j.micpath.2023.106416 contributor: fullname: Tabassum – volume: 47 start-page: 699 issue: 6 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib84 article-title: Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies publication-title: Crit Rev Microbiol doi: 10.1080/1040841X.2021.1921696 contributor: fullname: Khan – volume: 14 start-page: 32855 issue: 29 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib12 article-title: Evaluation of the antimicrobial activity in host-mimicking media and in vivo toxicity of antimicrobial polymers as functional mimics of AMPs publication-title: ACS Appl Mater Interfaces doi: 10.1021/acsami.2c05979 contributor: fullname: Garcia Maset – volume: 2 start-page: 95 issue: 2 year: 2004 ident: 10.1016/j.bioflm.2024.100192_bib20 article-title: Bacterial biofilms: from the natural environment to infectious diseases publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro821 contributor: fullname: Hall-Stoodley – volume: 13 start-page: 62 issue: 1 year: 2011 ident: 10.1016/j.bioflm.2024.100192_bib54 article-title: 3-indolylacetonitrile decreases Escherichia coli O157:H7 biofilm formation and Pseudomonas aeruginosa virulence publication-title: Environ Microbiol doi: 10.1111/j.1462-2920.2010.02308.x contributor: fullname: Lee – volume: 6 start-page: 8503 issue: 10 year: 2016 ident: 10.1016/j.bioflm.2024.100192_bib33 article-title: Pyoverdin mediated sunlight induced green synthesis of silver nanoparticles publication-title: RSC Adv doi: 10.1039/C5RA20856D contributor: fullname: Dane – year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib41 article-title: Pseudomonas aeruginosa virulence attenuation by inhibiting siderophore functions publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-022-12347-6 contributor: fullname: Jeong – volume: 43 start-page: 938 issue: 3 year: 2012 ident: 10.1016/j.bioflm.2024.100192_bib83 article-title: Bactericidal antibiotic-phytochemical combinations against methicillin resistant Staphylococcus aureus publication-title: Braz J Microbiol doi: 10.1590/S1517-83822012000300013 contributor: fullname: Kyaw – volume: 6 start-page: 4180 issue: 23 year: 2014 ident: 10.1016/j.bioflm.2024.100192_bib72 article-title: Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety publication-title: Nanoscale doi: 10.1039/C4NR04970E contributor: fullname: Kim – volume: 98 start-page: 50 year: 2016 ident: 10.1016/j.bioflm.2024.100192_bib75 article-title: Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae publication-title: Microb Pathog doi: 10.1016/j.micpath.2016.06.016 contributor: fullname: Ahmed – volume: 7 year: 2016 ident: 10.1016/j.bioflm.2024.100192_bib23 article-title: Interspecific bacterial interactions are reflected in multispecies biofilm spatial organization publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01366 contributor: fullname: Liu – year: 2023 ident: 10.1016/j.bioflm.2024.100192_bib64 article-title: pH-responsive polymeric nanomaterials for the treatment of oral biofilm infections publication-title: Colloids Surf B Biointerfaces contributor: fullname: Jeong – volume: 211 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib49 article-title: Inhibitory activities of phloroglucinol-chitosan nanoparticles on mono- and dual-species biofilms of Candida albicans and bacteria publication-title: Colloids Surf B Biointerfaces doi: 10.1016/j.colsurfb.2021.112307 contributor: fullname: Khan – volume: 8 start-page: 68 issue: 1 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib61 article-title: Translational challenges and opportunities in biofilm science: a BRIEF for the future publication-title: NPJ Biofilms Microbiomes doi: 10.1038/s41522-022-00327-7 contributor: fullname: Highmore – volume: 11 year: 2021 ident: 10.1016/j.bioflm.2024.100192_bib79 article-title: Subinhibitory concentrations of biogenic silver nanoparticles affect motility and biofilm formation in Pseudomonas aeruginosa publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2021.656984 contributor: fullname: Saeki – volume: 24 start-page: 203 issue: 3 year: 1997 ident: 10.1016/j.bioflm.2024.100192_bib44 article-title: A simple artificial urine for the growth of urinary pathogens publication-title: Lett Appl Microbiol doi: 10.1046/j.1472-765X.1997.00378.x contributor: fullname: Brooks – volume: 170 year: 2022 ident: 10.1016/j.bioflm.2024.100192_bib89 article-title: Superior inhibition of virulence and biofilm formation of Pseudomonas aeruginosa PAO1 by phyto-synthesized silver nanoparticles through anti-quorum sensing activity publication-title: Microb Pathog doi: 10.1016/j.micpath.2022.105678 contributor: fullname: Kumar – volume: 54 start-page: 667 issue: Pt 7 year: 2005 ident: 10.1016/j.bioflm.2024.100192_bib42 article-title: Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung publication-title: J Med Microbiol doi: 10.1099/jmm.0.45969-0 contributor: fullname: Sriramulu – volume: 17 start-page: 141 issue: 3 year: 2019 ident: 10.1016/j.bioflm.2024.100192_bib81 article-title: Drug combinations: a strategy to extend the life of antibiotics in the 21st century publication-title: Nat Rev Microbiol doi: 10.1038/s41579-018-0141-x contributor: fullname: Tyers |
SSID | ssj0002313720 |
Score | 2.3375518 |
Snippet | The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the... |
SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 100192 |
SubjectTerms | Antibiofilm Antivirulence Host-mimicking media Pyoverdine Silver nanoparticles |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yIHgRv31-EcFrMUnTpvW2issiKIIu7C3kq9rFTZfX18Pzr3cmaZdXPezFQy9NSJuZSeYXMvMbQt7UQvFONawA31YWMkhZWG-7ggdAx7VrQi0wwfnzl_r0TH46r84PSn1hTFimB86CewsjtVXHQukaKx3rrPPMA6zgsPP61oe0-7L24DB1kUhcOJZfWXLlUkCX7YfuFyafC5mYh1qx8kWJsn_lkv6FnH9HTh64opN75O6MIelx_vf75FaID8jtXFVy_5Bcfusx3JlGE-FEPAe-0XEfAeuN_e_gKeaU0K9jmPwAVmhGasJ2-tHHYTT0ao9BneDRwjt6HDGjBIt6X1ITPTxYa2I7pUQlajAra3xEzk4-fv9wWsxVFQpXlWxX-NIy0zYW5KcEaDCYrhaOO8OFcLKTnautYsxxrpyUZeNRZyBxLpVt4HBUPiZHcYjhKaEc6cHwptTXAARE2RrhuXBOBSMq3_INKRb56qtMnqGXqLILnfWhUR8662ND3qMSrvsi9XV6AQahZ3npmwxiQ9SiQj2jiIwOYKj-hs-_XjSuYZHhzYmJYZhGnc6hyJQDfZ5kC7j-ybKppFQSWpqVbaxmsW6J_c9E5A12C_CoLZ_9j3k_J3dwLjmM7QU52m2n8BIA086-SmvjD7_nFxk priority: 102 providerName: Directory of Open Access Journals |
Title | Silver nanoparticles synthesized from Pseudomonas aeruginosa pyoverdine: Antibiofilm and antivirulence agents |
URI | https://dx.doi.org/10.1016/j.bioflm.2024.100192 https://www.ncbi.nlm.nih.gov/pubmed/38544742 https://search.proquest.com/docview/3014005092 https://pubmed.ncbi.nlm.nih.gov/PMC10966193 https://doaj.org/article/1f795f0e3c8b4c0fbcd0d6501362d9de |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJoNBL6bubtkGFXp21ZFm2e0tDQyikBNpAbkIvpw5ZeVmvD9tf3xnZDnF7KPTgi-WHpBkxn-xvviHko-QFq4syTSC2ZYnwQiTGmTphHtCxtKWXHBOcL77J8yvx9Tq_3iNyyoWJpH1rmuNwtzoOzc_IrVyv7HLiiS0vL04Z4G4A_tlyn-yDhz7Yo99GAReGpVemPLlI5jJNW99h4jkXUXWo4rM4FOX6Z-Hob7j5J2vyQRg6e0qejPiRngz9fEb2fHhOHg0VJXcvyOp7g1RnGnSA3fA4GNrtAuC8rvnlHcV8EnrZ-d614IG6o9pv-psmtJ2m6x0SOiGa-U_0JGA2CRb0XlEdHBxYZ2LTxyQlqjEjq3tJrs6-_Dg9T8aKConNs3SbuMykuioNRK2Cg_W8riW3zGrGuRW1qK00RZpaxgorRFY6tJeTAKoKU8KcZ6_IQWiDf0MoQ2kw_EvqJIAAnlWaO8atLbzmuavYgiTT_Kr1IJyhJkbZrRrsodAearDHgnxGI9xfi7LX8US7uVHjfClwqyqvU5_Z0gib1sY6eH-OunPcVc4vSDGZUI0IYkAG8KjmH6__MFlcwQLDvyY6-LbvVNyDokoOXPN68ID7TmZlLkQhoKWc-cZsFPMW8Oko4j358OH_3_qWPMYRDMS1d-Rgu-n9e4BIW3MUPy0cxXXxG6XsFmU |
link.rule.ids | 230,315,730,783,787,867,888,2109,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYIL78LyNBLXbGPHeXErFdUC3aoSrejN8iuQ0nVWm81h--uZcTZVtxwQHHKJs0lm_VnzWfnmG0LeZzxnVV7EEeS2JBJOiEhbXUXMATvOTOEyjgXO06Nsciq-nKVnWyQbamGCaN_oeuwvZmNf_wzayvnM7A46sd3j6T4D3g3EP9m9RW7Dgo3FtV36ebBwYdh8ZaiUC3IuXTfVBZaecxF8h0q-kYmCYf9GQvqTcN7UTV5LRAcPyPchhF5_8mvcLfXYXN5wd_z3GB-S-2tuSvf68Udky_nH5E7frXL1hMy-1Sijpl552Gmvb0LblQcO2daXzlKsVaHHretsA-hWLVVu0cF7Na2i8xWKRSFTug90z2OlCjYLn1HlLRzYw2LRhQIoqrDaq31KTg8-nexPonW3hsikSbyMbKJjVRYaMmLOARlOVRk3zCjGuRGVqEym8zg2jOVGiKSwiAWbAWHLdQGxJjtk2zfePSeUoe0YfoG1GRAMnpSKW8aNyZ3iqS3ZiETDzMl5b8ohB7XauexnWuJMy36mR-QjTu_VtWipHU40ix9y_X9JgGyZVrFLTKGFiSttLDw_RU87bkvrRiQfwCHX7KRnHXCr-i-PfzdgScLixS8yyruma2XY36IDD1zzrMfW1UsmRSpELmCk2EDdRhSbI4ClYBA-YOfF___0Lbk7OZkeysPPR19fknsYTS-Qe0W2l4vOvQYqttRvwrr7DSsZN5o |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLagCMSFvTCsRuKamdhxNm6lMCpLq5GgUiUOlrdASscZTSaH6a_nvSxVUw5IPeSSeJK88We9z8r3vkfIu4SnrEizMIDcFgXCCRFoq4uAOWDHiclcwrHA-fAoOTgWX07ik15VWfeySm90OfVny6kvf7faytXSzAad2GxxuM-AdwPxj2YrW8xukluwaMPk0k79tLVxYdiAZaiWayVduqyKMyw_56L1Hsr5KBu1pv2jpPQv6byqnbyUjOb3yc8hjE6D8mfabPTUnF9xeLxenA_IvZ6j0r1uzENyw_lH5HbXtXL7mCy_lyinpl552HH3N6L11gOXrMtzZynWrNBF7RpbAcpVTZVbN_BuVa3oaouiUciY7j3d81ixgk3Dl1R5Cwf2slg3bSEUVVj1VT8hx_NPP_YPgr5rQ2DiKNwENtKhyjMNmTHlgBCnioQbZhTj3IhCFCbRaRgaxlIjRJRZxIRNgLilOoN4o12y4yvvnhHK0H4Mv8TaBIgGj3LFLePGpE7x2OZsQoJh9uSqM-eQg2rtVHazLXG2ZTfbE_IBp_hiLFprtyeq9S_Z_18SoJvHRegik2lhwkIbC8-P0duO29y6CUkHgMiepXTsA25V_ufxbwc8SVjE-GVGeVc1tWz3uejEA2Oedvi6eMkoi4VIBVzJRsgbRTG-AnhqjcIH_Dy__k_fkDuLj3P57fPR1xfkLgbT6eRekp3NunGvgJFt9Ot26f0Fv0Q6Gg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Silver+nanoparticles+synthesized+from+Pseudomonas+aeruginosa+pyoverdine%3A+Antibiofilm+and+antivirulence+agents&rft.jtitle=Biofilm&rft.au=Tabassum%2C+Nazia&rft.au=Khan%2C+Fazlurrahman&rft.au=Jeong%2C+Geum-Jae&rft.au=Jo%2C+Du-Min&rft.date=2024-06-01&rft.pub=Elsevier&rft.eissn=2590-2075&rft.volume=7&rft_id=info:doi/10.1016%2Fj.bioflm.2024.100192&rft.externalDBID=PMC10966193 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-2075&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-2075&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-2075&client=summon |